Health Research Ethics Board of Alberta Approves ATMA's Phase II Psilocybin Clinical Trial with Group and Individual Therapy Settings
/PRNewswire/ - ATMA Journey Centers Inc. ("ATMA"), a pioneering Canadian company with a primary focus on advancing innovative psychedelic-assisted therapy...
Source: prnewswire.com